Table 2.

Differential metabolites in unresectable and resectable PDAC patients.

VIP	mz	RT	HMDB_ID	Adduct	Name	Formula	P	LOG2FC(un/res)
2.06	163.1328179	5.70	HMDB0033625	M+H	(3R,7R)-1,3,7-Octanetriol	C8H18O3	4.21E-13	-29.61
1.59	171.0653969	5.38	HMDB0000341	M-H	2-Octenedioic acid	C8H12O4	1.41E-20	-1.31
1.33	207.0405978	5.30	HMDB0000341	M+Cl	2-Octenedioic acid	C8H12O4	1.99E-09	-5.44
1.29	188.0170452	1.62	HMDB0001476	M+Cl	3-Hydroxyanthranilic acid	C7H7NO3	2.55E-13	-1.52
2.04	424.3421819	9.14	HMDB0006461	M+H	Linoelaidyl carnitine	C25H45NO4	4.76E-13	-34.85
1.34	279.2325866	11.10	HMDB0000673	M-H	Linoleic acid	C18H32O2	4.84E-15	-1.54
1.96	438.2982461	9.46	HMDB0011152	M+H	LysoPE(P-16:0/0:0)	C21H44NO6P	1.10E-11	-29.85
1.35	281.2481374	11.66	HMDB0000207	M-H	Oleic acid	C18H34O2	6.56E-15	-1.48
1.33	255.2324846	11.53	HMDB0000220	M-H	Palmitic acid	C16H32O2	8.90E-15	-1.64
1.16	882.5904013	13.15	HMDB0008321	M+Na	PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	C50H86NO8P	3.64E-04	-30.40
1.30	682.4040779	5.41	HMDB0008856	M+Cl	PE(14:1(9Z)/15:0)	C34H66NO8P	1.21E-13	-4.01
1.33	646.4261523	11.65	HMDB0008856	M-H	PE(14:1(9Z)/15:0)	C34H66NO8P	1.97E-11	-1.07
2.11	796.5259999	11.09	HMDB0009710	M+Na	PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	C45H76NO7P	2.37E-14	-35.09
2.02	796.526071	11.65	HMDB0009710	M+Na	PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	C45H76NO7P	1.09E-12	-36.20
1.23	772.5299073	11.10	HMDB0009710	M-H	PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	C45H76NO7P	3.39E-08	1.16

FC(un/res) represent the fold change of unresecble PDAC/ Resecble PDAC patients.